LATEST NEWS

MBMbio announced residency at JLABS @ Shanghai to further develop a novel RBC Liquid Biopsy Technology Platform

Bridging Global Innovations in Precision Medicine

We have built a closed-loop commercialization platform to
translate technological advances into healthcare
solutions that improve patient care.

Digital Pathology Software


A.I. based software solutions for cancer tissue pathology

MBMbio- intelligence


A.I. adapted digital pathology scanner

Novel RBC Liquid Biopsy


A novel red blood cell (RBC) based liquid biopsy platform for cancers

Clinical Research Lab


CAP and CLIA ready clincal
laboratory

Digital Pathology Software


A.I.-based software solutions
for cancer tissue pathology
analysis

MBMbio- intelligence


Made for A.I. digital
pathology scanner

Novel Red Blood Cell Liquid
Biopsy

Liquid biopsy platform for
early stage cancer monitoring

Clinical Research Lab


CAP and CLIA ready clincal
laboratory

Our Story

Our work begins with a passion for global innovations that can positively impact clinical practice

MBM was started with a basic insight that discoveries in the lab require significant transformation before it can ultimately reach patients. Since our founding, we have assembled the people and capabilities to bridge this gap.

Our Impact

Advancing Cancer Care
Through Precision
Medicine.

Our technology solutions include precision medicine products and
services that are designed to improve the quality of cancer care.

  • Digital Pathology Software
  • MBMbio-Intelligence
  • Novel Red Blood Cell Liquid Biopsy
  • Clinical Research Lab Services

Partnerships

Building a Stronger, Healthier
Future Together

Solving problems in cancer treatment is a complicated job. At MBM, we believe this challenge is best solved through a network and foundation of strategic partnerships.

Latest Blog Posts

News and healthcare tips

It all starts with a pursuit to transform cancer patient care.